Skip to main content

Advertisement

ADVERTISEMENT

Hidradenitis Suppurativa News

News
09/21/2022
Jessica Garlewicz, Associate Digital Editor
According to a study published in the Journal of the American Academy of Dermatology, screening efforts on comorbidities in hidradenitis suppurativa should be encouraged.
According to a study published in the Journal of the American Academy of Dermatology, screening efforts on comorbidities in hidradenitis suppurativa should be encouraged.
According to a study published...
09/21/2022
The Dermatologist
News
09/09/2022
Researchers aimed to provide expert consensus recommendations regarding COVID-19 vaccination in patients with HS.
Researchers aimed to provide expert consensus recommendations regarding COVID-19 vaccination in patients with HS.
Researchers aimed to provide...
09/09/2022
The Dermatologist

Advertisement

News
08/23/2022
Researchers aimed to identify potential patient characteristics and inclusion criteria for future pediatric HS studies in a dual analysis, cross-sectional, and descriptive study.
Researchers aimed to identify potential patient characteristics and inclusion criteria for future pediatric HS studies in a dual analysis, cross-sectional, and descriptive study.
Researchers aimed to identify...
08/23/2022
The Dermatologist
News
08/22/2022
Researchers aimed to analyze the outcome of different treatment methods after radical excision of hidradenitis suppurativa.
Researchers aimed to analyze the outcome of different treatment methods after radical excision of hidradenitis suppurativa.
Researchers aimed to analyze the...
08/22/2022
The Dermatologist
News
07/29/2022
Jessica Garlewicz, Associate Digital Editor
Researchers aimed to analyze the role of keratinocytes in HS lesion formation by comparing the transcriptomes of lesional and perilesional epidermis isolated from patients with HS.
Researchers aimed to analyze the role of keratinocytes in HS lesion formation by comparing the transcriptomes of lesional and perilesional epidermis isolated from patients with HS.
Researchers aimed to analyze the...
07/29/2022
The Dermatologist

Advertisement

News
07/21/2022
Jessica Garlewicz, Associate Digital Editor
Researchers identified adult patients undergoing THA or TKA for degenerative etiologies from PearlDiver datasets to match with patients without HS based on age, sex, and Elixhauser Comorbidity Index.
Researchers identified adult patients undergoing THA or TKA for degenerative etiologies from PearlDiver datasets to match with patients without HS based on age, sex, and Elixhauser Comorbidity Index.
Researchers identified adult...
07/21/2022
The Dermatologist
News
04/27/2022
Researchers aimed to investigate the spectrum of diseases associated with pyoderma gangrenosum and correlate disease associations with effectiveness of therapy.
Researchers aimed to investigate the spectrum of diseases associated with pyoderma gangrenosum and correlate disease associations with effectiveness of therapy.
Researchers aimed to investigate...
04/27/2022
The Dermatologist
News
04/13/2022
Researchers aimed to evaluate the associations of internalized skin bias with age, adverse psychopathology, and HRQOL in adult patients with HS.
Researchers aimed to evaluate the associations of internalized skin bias with age, adverse psychopathology, and HRQOL in adult patients with HS.
Researchers aimed to evaluate...
04/13/2022
The Dermatologist

Advertisement

News
03/30/2022
Lisa Kuhns, PhD
This study was performed at the dermatology department of the University of Modena and Reggio Emilia between January 2018 and June 2021.
This study was performed at the dermatology department of the University of Modena and Reggio Emilia between January 2018 and June 2021.
This study was performed at the...
03/30/2022
The Dermatologist
News
01/18/2022
Jessica Garlewicz, Associate Digital Editor
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials,...
01/18/2022
The Dermatologist

Advertisement